Under Trump, FDA Seeks To Abandon Expert Reviews of New Drugs

FDA leaders under President Donald Trump are moving to abandon a decades-old policy of asking outside experts to review drug applications, a move critics say would shield the agency’s decisions from public scrutiny. The agency “would like to get away” from assembling panels of experts to examine and vote on individual drugs, because “I don’t…

Read More

Hospitals Leaders Share How They’re Balancing Finance, Innovation and Patient Care

During a recent panel, hospital leaders discussed how they approach the balancing act between innovation and financial sustainability. They shared tactics such as reassessing vendor contracts, leaning into existing tech capabilities and finding creative ways to support patients without compromising margins. The post Hospitals Leaders Share How They’re Balancing Finance, Innovation and Patient Care appeared…

Read More

THCB Gang Episode 14, Friday November 14

Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday November 14 at 1PM PT 4PM ET. Today we have also a special guest – former Permanente Medical Group CEO Dr Robbie Pearl @robertpearlmd. Robbie has been diving into AI in his latest book ChatGPT-MD and we’ll be chatting about that as well as his forecasts for health…

Read More

Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence

By fostering collaboration and seamless data integration into healthcare systems, the industry is laying the groundwork for a future in which “personalized medicine” is so commonplace within clinical practice that we will just start calling it “medicine.” The post Driving Genetic Testing Adoption and Improved Patient Care through Health Data Intelligence appeared first on MedCity…

Read More